Tositumomab

From Proteopedia

Revision as of 06:38, 6 December 2010 by David Canner (Talk | contribs)
Jump to: navigation, search

Pharmacokinetics

Anti-CD20 Monoclonal Antibody Pharmacokinetics
Parameter Tositumomab Ofatumumab Rituximab Ibritumomab
Tmax (hr) Tositumomab Ofatumumab Rituximab Ibritumomab
Cmax (ng/ml) Tositumomab Ofatumumab Rituximab Ibritumomab
Bioavailability (%) Tositumomab Ofatumumab Rituximab Ibritumomab
Protein Binding (%) Tositumomab Ofatumumab Rituximab Ibritumomab
T1/2 (hr) Tositumomab Ofatumumab Rituximab Ibritumomab
AUC (ng/ml/hr) Tositumomab Ofatumumab Rituximab Ibritumomab
Clearance (L/h) Tositumomab Ofatumumab Rituximab Ibritumomab
IC50 (nM) Tositumomab Ofatumumab Rituximab Ibritumomab
Dosage (mg) Tositumomab Ofatumumab Rituximab Ibritumomab
Metabolism Tositumomab Ofatumumab Rituximab Ibritumomab

|}

Proteopedia Page Contributors and Editors (what is this?)

David Canner

Retrieved from "http://52.214.119.220/wiki/index.php/Tositumomab"
Personal tools